Condition: Spondyloarthritis (SpA) · Ankylosing Spondylitis (AS) · Sponsor: Nanfang Hospital, Southern Medical University
The purpose of the study is to verify the clinical feasibility of Benzathine penicillin (BPG) /Etanercept (ETN) combination regimen in patients with spondyloarthritis (SpA) and at the same time compare Benzathine penicillin /Etanercept combination regimen and Etanercept maintenance therapy in reducing disease activity, improving patients' clinical symptoms and body function scores, enhancing quality of life, improving imaging performance and safety.
This description comes directly from the study's public registry record.
Jun Xiao · 0086-20-18665000156 · orthopaedxj@163.com
Always discuss trial participation with your own doctor first.
| Anhui Provincial Hospital | Hefei, Anhui, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Nan Fang Hospital, Southern Medical University | Guangzhou, Guangdong, China | Recruiting |
| Nan Fang Hospital, Southern Medical University | Guangzhou, Guangdong, China | Recruiting |
| Inner Mongolia People's Hospital | Hohhot, Inner Mongolia, China | Not Yet Recruiting |
| Ganzhou People's Hospital | Ganzhou, Jiangxi, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06707194